Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

The Russian Ministry of Health has granted Marketing Authorisation to R-Pharm JSC for the development of Glatirat, a drug intended for the treatment of patients with relapsing-remitting multiple...

US patients with multiple sclerosis could soon gain access to a new treatment option after the US Food and Drug Administration approved Biogen and AbbVie's once-monthly, self-administered...

Researchers have discovered a gene involved in deregulation of certain immune cells in multiple sclerosis.

Characterised by the onset of chronic, neurodegenerative damage of the central...

For the first time scientists have been able to demonstrate a correlation between the blood coagulation system and the development of multiple sclerosis (MS), the University of Duisburg-Essen has...

New evidence suggests a diet mimicking the effects of fasting has health benefits beyond weight loss, with a USC-led study indicating it may reduce symptoms of multiple sclerosis.

...

A recent study has found that Andrographis paniculata (A. paniculata), or green chiretta reduces fatigue in patients with relapsing-remitting MS (RRMS) who are also receiving beta interferon,...

The Yissum Research Development Company, an arm of Hebrew University of Jerusalem, has entered into an agreement with Aurum Ventures MKI to develop a diagnostic blood test for relapsing-remitting...

Scorpions, snakes, snails, frogs and other creatures are thought to produce tens or even hundreds of millions of distinct venoms.

These venoms have been honed to strike specific targets in...

This World MS Day the MS International Federation has released a report, based on a global survey, which highlights the need for reasonable adjustments to help people with MS continue working....

A mutation in a mouse model of the John Cunningham (JC) virus, which causes progressive multifocal leukoencephalopathy (PML), allows the virus to evade the host immune responses in people with...

Pages

Live Chat Software by Click4Assistance UK